drugset / Trial / NCT00004236

Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer

NCT00004236 ↗

Phase 2 Unknown University of Leicester
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of liposomal doxorubicin in treating patients who have advanced stomach cancer.

Timeline

Start
1998-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified — Intravenous